Where Tech Meets Bio
Subscribe
Sign in
Home
Podcast
Archive
About
Latest
Top
Discussions
Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces
My interview with Dr. Brian Jamieson. We talk about the opportunities and challenges of BCI tech, Neuralink, and the transformative potential of BCIs in…
Apr 5, 2024
•
Andrii Buvailo
32
Share this post
Where Tech Meets Bio
Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces
Copy link
Facebook
Email
Notes
More
42:03
The '4th Wave' of AI Drug Discovery is Here, According to This Report
I’ve come across a really well-put report on the evolving state of artificial intelligence (AI) in drug discovery in 2024 and beyond, authored by Chris…
Dec 12, 2024
•
Andrii Buvailo
23
Share this post
Where Tech Meets Bio
The '4th Wave' of AI Drug Discovery is Here, According to This Report
Copy link
Facebook
Email
Notes
More
11 Biopharma Trends to Watch in 2024
Including some challenges and open questions.
Dec 29, 2023
•
Andrii Buvailo
14
Share this post
Where Tech Meets Bio
11 Biopharma Trends to Watch in 2024
Copy link
Facebook
Email
Notes
More
Where Are We Now With AI-driven Drug Discovery?🎄
The new research article raises important questions to focus on in 2025...
Dec 27, 2024
•
Andrii Buvailo
and
BiopharmaTrend
13
Share this post
Where Tech Meets Bio
Where Are We Now With AI-driven Drug Discovery?🎄
Copy link
Facebook
Email
Notes
More
2
First Week Highlights of 2024
ALSO: Inside the workings of one of biotech industry’s most valuable private startups; the world's first real-time pathogen detection device; preventing…
Jan 8, 2024
18
Share this post
Where Tech Meets Bio
First Week Highlights of 2024
Copy link
Facebook
Email
Notes
More
'Google Maps' of Human Cells
ALSO: World Models in Biotech — the Next Frontier; Antibody Design Without Binders, Transforming Clinical Trial Recruitment, and more...
Nov 26, 2024
•
BiopharmaTrend
,
Roman Kasianov
, and
Andrii Buvailo
12
Share this post
Where Tech Meets Bio
'Google Maps' of Human Cells
Copy link
Facebook
Email
Notes
More
FDA’s AI Drug Development Guidelines and What’s Next for Biopharma M&A
Also: One-Third of Pharma Molecules Now Come from China, Weekly Highlights...
Jan 14
•
BiopharmaTrend
,
Roman Kasianov
, and
Andrii Buvailo
11
Share this post
Where Tech Meets Bio
FDA’s AI Drug Development Guidelines and What’s Next for Biopharma M&A
Copy link
Facebook
Email
Notes
More
2
AI Foundation Models in Biotech: New Paradigm
The rise of AI foundation models in biotech, companies on the cutting-edge. Biology is a new frontier. Data is still a bottleneck.
Oct 1, 2023
•
Andrii Buvailo
11
Share this post
Where Tech Meets Bio
AI Foundation Models in Biotech: New Paradigm
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #13
In Brief; Spotlight; R&D Corner; Quick Hits; Companies to Watch (Precision Medicine +AI); Takeaway of the Week; Bonus Takeaway
Aug 20, 2024
13
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #13
Copy link
Facebook
Email
Notes
More
2
14 Foundation Models for Biology Research and Chemistry
A list of companies building foundation models focused on DNA, RNA, proteins, as well as foundation models for small molecule drug discovery and organic…
Jun 21, 2024
9
Share this post
Where Tech Meets Bio
14 Foundation Models for Biology Research and Chemistry
Copy link
Facebook
Email
Notes
More
8 AI Companies to Watch in Clinical Trials
ALSO: A Map of Antibiotic Resistance; Deep Mind Introduces Tx-LLM; Antibody Discovery Beyond AlphaFold; LLC Business Model in Biotech
Oct 21, 2024
•
Andrii Buvailo
,
Roman Kasianov
, and
BiopharmaTrend
8
Share this post
Where Tech Meets Bio
8 AI Companies to Watch in Clinical Trials
Copy link
Facebook
Email
Notes
More
2
Weekly Tech+Bio Highlights #7
ALSO: Embracing AI Transformation: Let’s Start with Data; The First R&D Platform Using Human Neurons for Biocomputing; This AI-driven Antibody Design…
Jul 7, 2024
11
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #7
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts